Study guide
5.1 Glycemic Emergencies: DKA, HHS & Glucose Control
AACN PCCN Progressive Care Certified Nurse, Adult
Track your progress as you read
Finished sections get a check mark.
1 Introduction, the Synergy Model & Exam Strategy
1.1 The PCCN Credential & the Progressive Care Nurse 1.2 Exam Blueprint, Format & Scoring 1.3 The AACN Synergy Model & How to Study
2 Cardiovascular Foundations — Hemodynamics, ACS & Catheterization
2.1 Hemodynamic Monitoring in Progressive Care 2.2 Acute Coronary Syndromes: Unstable Angina, NSTEMI & STEMI 2.3 Cardiac Catheterization, PCI & Structural Heart Procedures
3 Cardiovascular — Pump Failure, Rhythm, Vessels & Inflammation
3.1 Heart Failure & Cardiogenic Shock 3.2 Cardiomyopathies & Valvular Heart Disease 3.3 Dysrhythmia Interpretation & Electrical Therapies 3.4 Hypertensive Crisis, Vascular Disease & Aneurysms 3.5 Cardiac Inflammatory Disease, Tamponade & Post-Cardiac-Surgery Care
4 Respiratory — Gas Exchange, Failure & Ventilation
4.1 ABG/VBG Interpretation & Acid-Base Balance 4.2 Respiratory Failure & Oxygenation Support 4.3 Obstructive & Inflammatory Airway Disease 4.4 Acute Lung Injury, Embolism & Pleural Disorders 4.5 Thoracic Surgery & Airway Procedures
5 Endocrine, Renal & Electrolytes
5.1 Glycemic Emergencies: DKA, HHS & Glucose Control 5.2 Fluid-Regulation & Thyroid Disorders 5.3 AKI, CKD/ESRD & Electrolyte Imbalances
6 Neurology, Gastrointestinal, Hematology & Musculoskeletal
6.1 Stroke, TBI & Space-Occupying Lesions 6.2 Seizures, Encephalopathy & Altered Mental Status 6.3 GI Bleeding, Motility & Surgical Conditions 6.4 Hepatic, Pancreatic & Nutritional Disorders 6.5 Hematology, Immunology & Oncology 6.6 Musculoskeletal: Mobility, Falls & Compartment Syndrome
7 Multisystem — Sepsis, Infection, Wounds & End-of-Life
7.1 Sepsis, SIRS & Shock States 7.2 Healthcare-Acquired & Infectious Diseases 7.3 Wounds, Pressure Injuries & Rhabdomyolysis 7.4 Pain, Palliative Care & End-of-Life 7.5 Toxic Ingestion, Overdose & Withdrawal
8 Behavioral/Psychosocial & Professional Caring / Ethical Practice
8.1 Behavioral & Psychosocial Care 8.2 Advocacy, Moral Agency & Ethical Practice 8.3 Caring Practices & Response to Diversity 8.4 Facilitation of Learning & Patient/Family Education 8.5 Collaboration & Systems Thinking 8.6 Clinical Inquiry & Evidence-Based Practice
5.1 Glycemic Emergencies: DKA, HHS & Glucose Control
Key Takeaways Explain This Topic AI
DKA requires all three of hyperglycemia (glucose >=200 mg/dL), ketosis (beta-hydroxybutyrate >=3.0 mmol/L), and acidosis (pH <7.3 and/or bicarbonate <18 mEq/L)
HHS presents with glucose >=600 mg/dL, effective osmolality >300 mOsm/kg, minimal ketosis, and a pH of 7.30 or higher
If serum potassium is below 3.5 mEq/L, insulin must be held and potassium replaced first to avoid life-threatening hypokalemia (2024 adult consensus)
DKA is resolved when plasma ketone (β-hydroxybutyrate) is <0.6 mmol/L and venous pH is ≥7.3 or bicarbonate is ≥18 mEq/L (ideally glucose <200 mg/dL); the anion gap and urine ketones are not used as resolution criteria, and a normal glucose alone is not resolution
- ADA hypoglycemia thresholds are <70 mg/dL (Level 1, alert) and <54 mg/dL (Level 2, requires immediate action)
- Last updated: October 2026
5.1 Glycemic Emergencies: DKA, HHS & Glucose Control
Endocrine content is only 6% of the PCCN blueprint, but diabetic ketoacidosis (DKA) and hyperosmolar hyperglycemic state (HHS) are among the most frequently tested emergencies because they combine acid-base, fluid, and electrolyte management into a single high-stakes scenario. Both are life-threatening complications of uncontrolled diabetes mellitus, but they differ enough in pathophysiology and presentation that the PCCN exam routinely asks you to tell them apart.
Diabetic Ketoacidosis (DKA)
DKA results from an absolute or relative insulin deficiency combined with excess counter-regulatory hormones (glucagon, cortisol, catecholamines, growth hormone). Without insulin to suppress lipolysis, fatty acids flood the liver and are converted to ketone bodies (beta-hydroxybutyrate and acetoacetate), producing a high-anion-gap metabolic acidosis . Simultaneously, reduced glucose uptake plus increased gluconeogenesis and glycogenolysis drive severe hyperglycemia, which causes an osmotic diuresis, dehydration, and major electrolyte losses.
Common triggers : infection (the most common precipitant), missed or inadequate insulin dosing, new-onset type 1 diabetes, myocardial infarction, pancreatitis, corticosteroid use, and SGLT2 inhibitors (which can cause "euglycemic DKA" with a near-normal glucose).
Classic presentation : polyuria and polydipsia, Kussmaul respirations (deep, rapid breathing that blows off CO2 to partially compensate for the metabolic acidosis), a fruity or acetone breath odor, nausea, vomiting, and abdominal pain that can mimic an acute surgical abdomen. Mental status ranges from alert to comatose depending on severity, and dehydration signs (tachycardia, hypotension, dry mucous membranes) are common.
Diagnostic criteria require all three: hyperglycemia (glucose ≥200 mg/dL or known diabetes), ketosis (beta-hydroxybutyrate ≥3.0 mmol/L or urine ketones ≥2+), and acidosis (pH <7.3 and/or bicarbonate <18 mEq/L). Severity is graded by pH and bicarbonate: mild (pH 7.25–7.30, bicarbonate 15–18), moderate (pH 7.00–7.24, bicarbonate 10 to <15), and severe (pH <7.00, bicarbonate <10).
Hyperosmolar Hyperglycemic State (HHS)
HHS typically occurs in older adults with type 2 diabetes , often triggered by infection, stroke, MI, or simple dehydration, and it develops over days rather than hours. Enough residual insulin remains to suppress significant ketogenesis, but not enough to control glucose, so the hallmark is profound hyperglycemia and hyperosmolality without significant acidosis .
Diagnostic criteria : glucose ≥600 mg/dL, effective serum osmolality >300 mOsm/kg (or total osmolality >320), minimal ketosis (beta-hydroxybutyrate <3.0 mmol/L), pH ≥7.30, and bicarbonate ≥15 mEq/L. Because acidosis is minimal, patients do not develop Kussmaul respirations or fruity breath. Presentation is dominated by neurologic findings — lethargy, confusion, focal deficits that can mimic stroke, seizures, or coma — correlating directly with the degree of hyperosmolality. Fluid deficits in HHS are typically larger than in DKA, often 8–10 liters.
- Feature DKA HHS
- Typical patient Type 1 (can occur in type 2) Type 2, often older adult
- Onset Hours Days
Glucose Usually ≥200 mg/dL, or any level with known diabetes (euglycemic DKA <200) Usually ≥600 mg/dL, often >1,000
- Ketones / pH Significant ketosis; pH <7.3 Minimal ketosis; pH ≥7.3
- Osmolality Less elevated Markedly elevated (>320 mOsm/kg)
- Kussmaul respirations Present Absent
- Mental status Variable Often severely altered
- Priorities of Care
Fluids first. Begin with isotonic 0.9% normal saline; the rate and total volume are guided by hydration status, hemodynamics, and cardiac/renal function. HHS patients generally need larger total volumes.
Potassium before, or with, insulin — a critical safety point. Insulin drives potassium intracellularly. Even though many DKA/HHS patients present with a normal or high serum potassium (acidosis shifts K+ out of cells), they are almost always total-body potassium depleted . Under the 2024 adult consensus, if serum K+ is below 3.5 mEq/L, hold insulin and replace potassium first (about 10 mEq/hr) — starting an insulin infusion in a hypokalemic patient can precipitate life-threatening dysrhythmias and respiratory muscle weakness. If K+ is 3.5–5.0 mEq/L, start the insulin infusion (typically 0.1 units/kg/hr) while replacing potassium concurrently (20–30 mEq per liter). If K+ is above 5.0 mEq/L, hold potassium replacement until it falls below 5.0, start insulin, and recheck 2 hours after insulin starts, then every 4 hours.
Titrate the insulin infusion carefully. Check glucose hourly. When glucose falls below 250 mg/dL in DKA (or to 250–300 mg/dL in HHS), add 5–10% dextrose to the IV fluids and reduce — rather than stop — the insulin rate, because glucose normalizes faster than ketosis resolves and the infusion must continue until the ketoacidosis resolves.
Know the true resolution criteria for DKA : DKA is resolved when plasma ketone (β-hydroxybutyrate) is <0.6 mmol/L and venous pH is ≥7.3 or bicarbonate is ≥18 mEq/L (ideally glucose <200 mg/dL); the anion gap and urine ketones are not used as resolution criteria. A normal glucose reading alone is not resolution. Overlap the first dose of subcutaneous (basal) insulin with the IV infusion by 1–2 hours before discontinuing the drip to prevent rebound ketoacidosis.
Watch for complications : cerebral edema (rare in adults but a feared complication, particularly if fluids/glucose are corrected too rapidly), hypoglycemia and hypokalemia from over-aggressive insulin therapy, and — in HHS — gradual correction of osmolality to avoid abrupt fluid shifts into the brain.
Hyperglycemia and Hypoglycemia
Hypoglycemia thresholds per the American Diabetes Association: Level 1 (alert value) is glucose <70 mg/dL ; Level 2 (clinically significant) is <54 mg/dL and requires immediate action; Level 3 (severe) is any hypoglycemia associated with altered mental status or physical function requiring assistance from another person, regardless of the glucose value. Adrenergic symptoms (tachycardia, diaphoresis, tremor, hunger, anxiety) typically appear before neuroglycopenic symptoms (confusion, slurred speech, seizure, coma) as glucose continues to fall — though this warning phase can be blunted by long-standing diabetes, autonomic neuropathy, or beta-blocker therapy ("hypoglycemia unawareness"). Treat a conscious patient who can swallow with 15–20 g of fast-acting carbohydrate, recheck in 15 minutes, and repeat if still below 70 mg/dL (the "rule of 15"). For an unconscious patient or one unable to swallow safely, give IV dextrose (D50W) or IM/intranasal glucagon if IV access is unavailable.